Evidence map›Paper›PMID 34050448›Full record

ArticleJournal of assisted reproduction and genetics2021

A threshold concentration of FSH is needed during IVM of ex vivo collected human oocytes.

Jesús Cadenas, Dmitry Nikiforov, Susanne Elisabeth Pors, Lenin Arturo Zuniga, Yu Wakimoto, Zeinab Ghezelayagh, Linn Salto Mamsen, Stine Gry Kristensen, Claus Yding Andersen

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Journal of assisted reproduction and genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05370794 (Is in Vitro Maturation of Oocytes Influenced by the Origin of Gonadotropins Used in Maturation Medium), which is not on this map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
4.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05370794 unknown statusnot on this mapstarted 2022, after this paper: background citation

Is in Vitro Maturation of Oocytes Influenced by the Origin of Gonadotropins Used in Maturation Medium: is There a Difference in Efficiency When Using Urinary Versus Recombinant Produced Follicle Stimulating Hormone and Human Chorionic Gonadotropin

Typeobservational_patient_registrySponsorUniversitair Ziekenhuis BrusselRan2022 to 2023Enrolled35ConditionsIn Vitro Maturation of OocytesArmsrhCG= Ovitrelle®, 250g/0.5ml = 26000IU/ml, Merck-Serono, rFSH = Gonal F®, 300IU/0.5ml, Merck-Serono
3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Moving the context of preserving fertility into an expanded domain.Journal of assisted reproduction and genetics · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Clinical Outcomes ofFrontiers in endocrinology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Jesús CadenasLaboratory of Reproductive Biology, The Juliane Marie Centre for Women, Children and Reproduction, University Hospital of Copenhagen, Rigshospitalet, Copenhagen, Denmark. jesus.cadenas.moreno@regionh.dk.ORCID http://orcid.org/0000-0001-8164-3697
Dmitry NikiforovLaboratory of Reproductive Biology, The Juliane Marie Centre for Women, Children and Reproduction, University Hospital of Copenhagen, Rigshospitalet, Copenhagen, Denmark.
Susanne Elisabeth PorsLaboratory of Reproductive Biology, The Juliane Marie Centre for Women, Children and Reproduction, University Hospital of Copenhagen, Rigshospitalet, Copenhagen, Denmark.
Lenin Arturo ZunigaLaboratory of Reproductive Biology, The Juliane Marie Centre for Women, Children and Reproduction, University Hospital of Copenhagen, Rigshospitalet, Copenhagen, Denmark.
Yu WakimotoLaboratory of Reproductive Biology, The Juliane Marie Centre for Women, Children and Reproduction, University Hospital of Copenhagen, Rigshospitalet, Copenhagen, Denmark.
Zeinab GhezelayaghLaboratory of Reproductive Biology, The Juliane Marie Centre for Women, Children and Reproduction, University Hospital of Copenhagen, Rigshospitalet, Copenhagen, Denmark.
Linn Salto MamsenLaboratory of Reproductive Biology, The Juliane Marie Centre for Women, Children and Reproduction, University Hospital of Copenhagen, Rigshospitalet, Copenhagen, Denmark.
Stine Gry KristensenLaboratory of Reproductive Biology, The Juliane Marie Centre for Women, Children and Reproduction, University Hospital of Copenhagen, Rigshospitalet, Copenhagen, Denmark.
Claus Yding AndersenLaboratory of Reproductive Biology, The Juliane Marie Centre for Women, Children and Reproduction, University Hospital of Copenhagen, Rigshospitalet, Copenhagen, Denmark.
Copenhagen University Hospital · DKHyogo Medical University · JPRoyan Institute · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo investigate the effect of different FSH concentrations on human oocyte maturation in vitro and its impact on gene expression of key factors in the surrounding cumulus cells.

methodsThe study included 32 patients who underwent unilateral oophorectomy for ovarian tissue cryopreservation (OTC) (aged 28 years on average). Immature oocytes were collected from surplus medulla tissue. A total of 587 immature oocytes were divided into three categories according to the size of the cumulus mass: large (L-COCs), small (S-COCs), and naked oocytes (NOs), and submitted to 44-h IVM with one of the following concentrations of recombinant FSH: 0 IU/L, 20 IU/L, 40 IU/L, 70 IU/L, or 250 IU/L. After IVM, oocyte nuclear maturation stage and diameter were recorded. The relative gene expression of FSHR, LHCGR, and CYP19A1 in cumulus cells before (day 0; D0) and after IVM were evaluated.

resultsAddition of 70 or 250 IU/L FSH to the IVM medium improved oocyte nuclear maturation compared to 0, 20, and 40 IU/L FSH by upregulating LHCGR and downregulating FSHR in the cumulus cells.

conclusionFSH improved oocyte nuclear maturation at concentrations above 70 IU/L suggesting a threshold for FSH during IVM of ex vivo collected human oocytes from small antral follicles. Moreover, current results for the first time highlight that FSH function in vitro is mediated via cumulus cells by downregulating FSHR and upregulating LHCGR, which was also observed when the immature oocytes progressed in meiosis from the GV to the MII stage.

Indexed as

In Vitro Oocyte Maturation TechniquesAdultAromataseBlastocystCumulus CellsFemaleFertilization in VitroFollicle Stimulating HormoneGene Expression Regulation, DevelopmentalHumansMeiosisOocytesOogenesisOvarian FollicleReceptors, FSHReceptors, LHAromataseCYP19A1 protein, humanFollicle Stimulating HormoneFSHR protein, humanLHCGR protein, humanReceptors, FSHReceptors, LHEx vivo collected oocytesFertility preservationFSHIVMSmall antral follicles

Identifiers

PMID34050448
PMCPMC8266958
OpenAlexW3165165426

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.